Related Experiment Video
Updated: May 5, 2026

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
45.2K
Does a glass of red wine improve endothelial function?
S Agewall1, S Wright, R N Doughty
1Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
European Heart Journal
|December 28, 1999
Summary
De-alcoholized red wine significantly improved endothelial function, unlike red wine with alcohol. Antioxidants in red wine, not ethanol, may offer cardiovascular protection.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Nutrition Science
Background:
- Endothelial dysfunction is a key factor in cardiovascular disease.
- Red wine consumption has been linked to cardiovascular benefits, but the role of alcohol versus non-alcoholic components is debated.
Purpose of the Study:
- To investigate the acute effects of red wine and de-alcoholized red wine on endothelial function.
Main Methods:
- 12 healthy young subjects underwent a randomized, cross-over study.
- Brachial artery flow-mediated dilatation was measured using high-frequency ultrasound after consuming red wine with or without alcohol.
Main Results:
- Red wine with alcohol increased brachial artery diameter and blood flow, attributed to ethanol.
- De-alcoholized red wine significantly increased flow-mediated brachial artery dilatation compared to red wine with alcohol and baseline.
Conclusions:
- Ethanol in red wine causes hemodynamic changes but does not enhance flow-mediated dilatation.
- The antioxidant properties of de-alcoholized red wine may be responsible for improved endothelial function, supporting their role in cardiovascular protection.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

